世華科技(688093.SH):擬2.2億元投建世華科技創新中心項目
格隆匯10月28日丨世華科技(688093.SH)公佈,基於材料科學研發的持續人才需求,進一步提升公司研發創新能力,實現公司的戰略發展佈局,2021年10月28日公司召開第二屆董事會第三次會議審議通過《關於公司全資子公司世晨材料技術(上海)有限公司對外投資的議案》,同意公司以全資子公司世晨材料技術(上海)有限公司(以下簡稱"上海世晨")為實施主體,於上海紫竹高新技術產業開發區建設"世華科技創新中心項目",項目投資總額約為2.2億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.